There were 153 press releases posted in the last 24 hours and 328,055 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Sarepta Therapeutics Announces Positive Safety and Efficacy Data from the SRP-9001 Micro-Dystrophin Gene Therapy Trial Published in JAMA Neurology

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image